| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | CA2744893A1 Aryl carbonyl derivatives as glucokinase activators |
| 01/08/2004 | CA2491271A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | CA2491089A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489411A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377640A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377263A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | CN1466585A Sodium sal ts of 5'-4'-2-(N-methyl-N-(2-pyridyl)amino) ethoxy [benzyl] thiazolidine-2,4-dione |
| 01/07/2004 | CN1466584A Tetrazolyl-phenyl acetamide glucokinase activators |
| 01/07/2004 | CN1466582A Substituted aryl ketones and their use as herbicides |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133627C Intermediate of N-benzyl dioxothiazolidinyl benzoyl amide derivatives, and its prepn. method |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133372C Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl] piperidines |
| 01/06/2004 | US6673821 Nitrogen heterocycle inhibitors of aspartyl protease |
| 01/06/2004 | US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/06/2004 | US6673816 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2 |
| 01/02/2004 | EP1375489A1 Medicinal composition containing 1,3-thiazine derivative |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1373265A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373244A2 Substituted benzopyranones as telomerase inhibitors |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373220A1 Benzimidazoles that are useful in treating sexual dysfunction |
| 01/02/2004 | EP1373210A1 Heterocyclic diamide invertebrate pest control agents |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372650A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/02/2004 | EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides |
| 01/01/2004 | US20040002600 Antibiotics |
| 01/01/2004 | US20040002545 For plants |
| 01/01/2004 | US20040002527 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002515 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 01/01/2004 | US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
| 01/01/2004 | US20040002495 Lactam glycogen phosphorylase inhibitors and method of use |
| 01/01/2004 | US20040002492 ATM inhibitors |
| 01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 01/01/2004 | US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
| 12/31/2003 | WO2004001059A2 Heterocyclic inhibitors of kinases |
| 12/31/2003 | WO2004000848A1 Process for the conversion of penam ring system to cepham ring system |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000838A1 Peptidic compounds as cysteine protease inhibitors |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000810A1 A process for the production of substituted phenyl ethers |
| 12/31/2003 | WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators |
| 12/31/2003 | WO2004000314A1 Methods of using benzothiophenone derivatives to treat cancer or inflammation |
| 12/31/2003 | WO2004000214A2 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions |
| 12/31/2003 | WO2003074513A3 Indole amide derivatives and their use as glycogen phosphorylase inhibitors |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | CN1132833C Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof |
| 12/30/2003 | US6670379 Piperidine compounds for use as ccr-3 inhibitors |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6670307 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS |
| 12/25/2003 | US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents |
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236262 Dietetics; antidiabetic agents; sexual disorders |
| 12/25/2003 | US20030236261 Potassium channel inhibitors |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/25/2003 | US20030236256 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives |
| 12/25/2003 | US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease |
| 12/25/2003 | US20030236251 Hepatitis virus viricides |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236227 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |